Drugs for Rett Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 79)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Risperidone |
Approved, Investigational |
Phase 3 |
|
106266-06-2 |
5073 |
Synonyms:
Belivon
Buspirone
Consta, risperdal
LY03004
LY-03004
N05AX08
Okedi®|R-64-766|R-64766|Risperdal®
PERSERIS KIT
R-64,766
R-64766
R-64-766
RCN3028
RCN-3028
Rispen
Risperdal
Risperdal consta
RISPERDAL CONSTA LONG ACTING
|
RISPERDAL M
Risperdal m-tab
RISPERDAL QUICKLET
RISPERDONE
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Rispéridone
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
Sequinan
Spiron
|
|
2 |
|
Dopamine |
Approved |
Phase 3 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
3 |
|
Cannabidiol |
Approved, Investigational |
Phase 3 |
|
13956-29-1 |
521372 644019 |
Synonyms:
(−)-trans-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol
(−)-trans-cannabidiol
(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydrobiphenyl-2,6-diol
BTX-1503
CANNABIDIOL
CBD
CBD|Epidiolex®|GWP42003-P|nabiximols (CBD + THC, fixed-dose oral spray)|Sativex® (CBD + THC, fixed-dose oral spray)
|
EPIDIOLEX
GWP42003
GWP-42003
GWP42003-P
GWP-42003-P
Δ1(2)-trans-cannabidiol
|
|
4 |
|
Ethanol |
Approved |
Phase 3 |
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
5 |
|
Strawberry |
Approved |
Phase 3 |
|
|
|
6 |
|
Glutamic acid |
Approved, Nutraceutical |
Phase 3 |
|
56-86-0 |
33032 |
Synonyms:
(+)-Estrone
(1S)-2-[(3-O-b-D-Glucopyranosyl-b-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoate
(1S)-2-[(3-O-b-D-Glucopyranosyl-b-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoic acid
(1S)-2-[(3-O-beta-D-Glucopyranosyl-beta-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoic acid
(1S)-2-[(3-O-Β-D-glucopyranosyl-β-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoate
(1S)-2-[(3-O-Β-D-glucopyranosyl-β-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoic acid
(2R)-2,3-Dihydroxypropanoic acid
(2S)-2-Aminopentanedioate
(2S)-2-Aminopentanedioic acid
(3R,4S,5R)-5-[(1R)-1-Carboxy-2,2-difluoro-1-(phosphonooxy)ethoxy]-4-hydroxy-3-(phosphonooxy)cyclohex-1-ene-1-carboxylate
(R)-2,3-Dihydroxypropanoic acid
(R)-Glycerate
(R)-Glyceric acid
(S)-(+)-Glutamate
(S)-(+)-Glutamic acid
(S)-2-Aminopentanedioate
(S)-2-Aminopentanedioic acid
(S)-Glutamate
(S)-Glutamic acid
1,3,5(10)-Estratrien-3-ol-17-one
1-Amino-2-hydroxyethane
1-Aminopropane-1,3-dicarboxylate
1-Amino-propane-1,3-dicarboxylate
1-Aminopropane-1,3-dicarboxylic acid
1-Amino-propane-1,3-dicarboxylic acid
2 Acetamido 2 deoxy D glucose
2 Acetamido 2 deoxyglucose
2 Aminoethanol
2-Acetamido-2-deoxy-D-glucose
2-Acetamido-2-deoxyglucose
2-Amino-1-ethanol
2-Aminoethan-1-ol
2-Aminoethanol
2-Amino-ethanol
2-Aminoethyl alcohol
2-Aminoglutarate
2-Aminoglutaric acid
2-Aminopentanedioate
2-Aminopentanedioic acid
2-Ethanolamine
2-Hydroxyethanamine
2-Hydroxyethylamine
3a,7a,12a-Trihydroxy-5b-cholan-24-oylglycine
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid-24-glycine
3alpha,7alpha,12alpha-Trihydroxy-N-(carboxymethyl)-5beta-cholan-24-amide
3-Hydroxy-1,3,5(10)-estratrien-17-one
3-Hydroxy-17-keto-estra-1,3,5-triene
3-Hydroxyestra-1,3,5(10)-trien-17-one
3-Hydroxyestra-1,3,5(10)-triene-17-one
3-Hydroxyoestra-1,3,5(10)-trien-17-one
3Α,7α,12α-trihydroxy-5β-cholan-24-oylglycine
3Α,7α,12α-trihydroxy-5β-cholanic acid-24-glycine
3Α,7α,12α-trihydroxy-N-(carboxymethyl)-5β-cholan-24-amide
a,b-Hydroxypropionate
a,b-Hydroxypropionic acid
a-Aminoglutarate
a-Aminoglutaric acid
Acetylglucosamine
Acide glutamique
Acido glutamico
ácido glutámico
Acidum glutamicum
Aciglut
Aethanolamin
a-Glutamate
a-Glutamic acid
alpha,beta-Hydroxypropionate
alpha,beta-Hydroxypropionic acid
alpha-Aminoglutarate
alpha-Aminoglutaric acid
alpha-Glutamate
alpha-Glutamic acid
Aluminum L glutamate
Aluminum L-glutamate
Aminoethanol
Aminoglutarate
Aminoglutaric acid
b-Aminoethanol
b-Aminoethyl alcohol
beta-Aminoethanol
beta-Aminoethyl alcohol
beta-Ethanolamine
beta-Hydroxyethylamine
b-Ethanolamine
b-Hydroxyethylamine
Cholylglycine
Colamine
D Glutamate
D1,3,5(10)-Estratrien-3-ol-17-one
D-2,3-Dihydroxypropanoic acid
D-GlcNAc
D-Glutamate
|
D-Glycerate
D-Glyceric acid
D-GroA
E
E 620
E620
E-620
Envision conditioner PDD 9020
Estrone, (+-)-isomer
Estrone, (8 alpha)-isomer
Estrone, (9 beta)-isomer
Estrovarin
ETA
Ethylolamine
FEMA NO. 3285
Follicular hormone
Folliculin
Glt
Glu
Glusate
Glut
Glutacid
Glutamate
Glutamate, potassium
GLUTAMIC ACID
Glutamic acid, (D)-isomer
Glutamicol
Glutamidex
Glutaminate
Glutaminic acid
Glutaminol
Glutaton
Glycerate
Glycine cholate
Glycinol
Glycocholate
Glycocholate sodium
Glycocholic acid, sodium salt
Glycoreductodehydrocholic acid
Glycylcholate
Glycylcholic acid
Hauck brand OF estrone
Hea
H-Glycinol
Hyrex brand OF estrone
INS NO.620
INS-620
Kestrone
L Glutamate
L Glutamic acid
L-(+)-Glutamate
L-(+)-Glutamic acid
L-a-Aminoglutarate
L-a-Aminoglutaric acid
L-alpha-Aminoglutarate
L-alpha-Aminoglutaric acid
L-Glu
L-Glu|L-glutamate|poly-L-glutamate
L-GLUTAMATE
L-Glutamate, aluminum
L-GLUTAMIC ACID
L-Glutaminate
L-Glutaminic acid
L-Glutaminsaeure
MEA
Monoaethanolamin
MONOETHANOLAMINE
N Acetyl D glucosamine
N-(Carboxymethyl)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-amide
N-(Carboxymethyl)-3α,7α,12α-trihydroxy-5β-cholan-24-amide
N-[(3a,5b,7a,12a)-3,7,12-Trihydroxy-24-oxocholan-24-yl]glycine
N-[(3alpha,5beta,7alpha,12alpha)-3,7,12-Trihydroxy-24-oxocholan-24-yl]glycine
N-[(3Α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl]glycine
N-Acetylchitosamine
N-Acetyl-D-glucosamine
N-Choloylglycine
N-Choloyl-glycine
NSC-143503
Oestrone
Olamine
Potassium glutamate
R-Glycerate
R-Glyceric acid
Unigen
Vortech brand OF estrone
Wehgen
Α,β-hydroxypropionate
Α,β-hydroxypropionic acid
Β-aminoethanol
Β-aminoethyl alcohol
Β-ethanolamine
Β-hydroxyethylamine
|
|
7 |
|
English Lavender |
|
Phase 3 |
|
|
|
8 |
|
Neurotransmitter Agents |
|
Phase 3 |
|
|
|
9 |
|
Psychotropic Drugs |
|
Phase 3 |
|
|
|
10 |
|
Antipsychotic Agents |
|
Phase 3 |
|
|
|
11 |
|
Dopamine Antagonists |
|
Phase 3 |
|
|
|
12 |
|
Dopamine Agents |
|
Phase 3 |
|
|
|
13 |
|
Anticonvulsants |
|
Phase 3 |
|
|
|
14 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
15 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 3 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
16 |
|
Benzocaine |
Approved, Investigational |
Phase 2 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
17 |
|
Tannic acid |
Approved |
Phase 2 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
18 |
|
Lovastatin |
Approved, Investigational |
Phase 2 |
|
75330-75-5 |
53232 |
Synonyms:
(+)-mevinolin|6α-methylcompactin|Mevacor®
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyric acid
1 alpha-Isomer lovastatin
2b,6a-Dimethyl-8a-(2-methyl-1-oxobutoxy)-mevinate lactone
2b,6a-Dimethyl-8a-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinate lactone
2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2β,6α-dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2Β,6α-dimethyl-8α-(2-methyl-1-oxobutoxy)-mevinate lactone
2Β,6α-dimethyl-8α-(2-methyl-1-oxobutoxy)-mevinic acid lactone
6 alpha-Methylcompactin
6 Methylcompactin
6-alpha-methylcompactin
6alpha-Methylcompactin
6a-Methylcompactin
6-Methylcompactin
6Α-methylcompactin
alpha-Isomer lovastatin, 1
Altocor
ALTOPREV
Artein
Belvas
C10AA02
Cholestra
Closterol
Colevix
Hipolip
Hipovastin
L-154803
Lestatin
Lipdip
Lipivas
Lipofren
|
Lovalip
Lovalord
Lovastatin
lovastatin lactone
Lovastatin, (1 alpha(s*))-isomer
Lovastatin, 1 alpha isomer
Lovastatin, 1 alpha-isomer
Lovastatina
Lovastatina [Spanish]
Lovastatine
Lovastatine [French]
Lovastatinum
Lovastatinum [Latin]
Lovasterol
Lovastin
Lozutin
Mevacor
MEVINACOR
MEVINACOR 10
MEVINACOR 40
Mevinolin
Mevlor
MK-803
ML-530b
Monacolin K
Nergadan
Paschol
Rodatin
Rovacor
SIMVASTATIN IMPURITY, LOVASTATIN-
Sivlor
Taucor
Tecnolip
Teroltrat
|
|
19 |
|
Ketamine |
Approved, Vet_approved |
Phase 2 |
|
6740-88-1, 1867-66-9 |
3821 |
Synonyms:
(-)-Ketamine
(+-)-Ketamine
(±)-ketamine
(S)-(-)-Ketamine
(S)-Ketamine
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(O-Chlorophenyl)-2-(methylamino)-cyclohexanone
Calipsol
Calypsol
CI 581 base
CLSTA 20
DL-Ketamine
Esketamine
Kalipsol
Ketaject
Ketalar
|
Ketalar base
Ketalar|ketamine HCl
Ketamina
KETAMINE
Kétamine
Ketamine base
Ketamine HCL
Ketamine hydrochloride
Ketaminum
Ketanest
Ketaset
Ketolar
L-Ketamine
NMDA
NSC-70151
Special K
Tekam
|
|
20 |
|
Cathine |
Approved, Experimental, Illicit, Vet_approved, Withdrawn |
Phase 2 |
|
14838-15-4, 492-39-7 |
131954576 4786 26934 |
Synonyms:
(+-)-Norephedrine
(+)-Norpseudoephedrine
(+-)-Phenylpropanolamine
2-AMINO-1-PHENYLPROPAN-1-OL
Cathina
Cathine
Cathinum
D-Cathine
Dexatrim
DL-Norephedrine
DL-Phenylpropanolamine
D-Norephedrine
d-Norpseudoephedrine
d-Nor-psi-ephedrine
FENILPROPANOLAMINA
Hydriatine
Hydrochloride, phenylpropanolamine
Katine
L-NOREPHEDRINE
L-Phenyl propanolamine
|
Mucorama
Nobese
NOREPHEDRIN
Norephedrine
Obestat
PHENYLPROPANOLAMIN
Phenylpropanolamina
Phenylpropanolamine
PHÉNYLPROPANOLAMINE
Phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINUM
PPA
Prestwick_388
Prolamine
Propadrine
Propagest
Pseudonorephedrine
psi-Norephedrine
Triaminic DM
Β-HYDROXYAMPHETAMINE
|
|
21 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 2 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
AMONIDRON
Aresol
Benylin-e
Breonesin
Bronchol
CVT-2534
Ether, guaiacol glyceryl
FAMEL
FRANOLYN CHESTY
GECOLATE
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
|
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
GUAIFENESIN OR GUAIPHENESIN
Guaifenesina
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
HUMABID
Humibid
Hustosil
Hytuss
LIQUFRUTA
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
MUCINEX
NIROLEX FOR CHESTY COUGH DECONGESTANT
NSC-62112
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
TIXYLIX CHESTY COUGH
|
|
22 |
|
Dextromethorphan |
Approved |
Phase 2 |
|
125-71-3 |
5362449 5360696 |
Synonyms:
(-)-3-Methoxy-17-methylmorphinan
(-)-3-Methoxy-N-methylmorphinan
(+)-DEXTROMETHORPHAN
(9S,13S,14S)-3-METHOXY-17-METHYLMORPHINAN
Antussan
Balminil DM
Balminil DM Children
Bayer select flu relief
Bayer select head & chest cold
Bayer select night time cold
Benylin Adult Formula Cough Suppressant
Benylin DM
Benylin DM 12 Hour
Benylin DM for Children
Benylin DM for Children 12 Hour
Benylin Pediatric Cough Suppressant
Calmylin #1
Canfodion
Cerose-DM
Chloraseptic DM
Contac day & night cold/flu day caplets
Contac jr. non-drowsy formula
Contac nighttime cold medicine
Contac severe cold formula maximum strength
Contac severe cold formula non-drowsy
Coricidin syrup
Cosylan
Cough-X
Creo-Terpin
Delsym
Delsym Cough Formula
delta-Methorphan
Demorphan
Demorphan hydrobromide
Demorphine
Destrometerfano
Destrometerfano [Dcit]
DEX
DEXTROMETHORFAN
Dextromethorfan [Czech]
DEXTROMETHORPHAN
Dextromethorphan bromhydrate
Dextromethorphan bromide
Dextromethorphan hydrobromide
Dextromethorphan hydrobromide monohydrate
Dextromethorphan hydrobromide oros tablets
Dextromethorphan hydrobromide, (+-)-isomer
Dextromethorphan hydrobromide, monohydrate
Dextromethorphan hydrochloride
Dextromethorphan, (+-)-isomer
DEXTROMÉTHORPHANE
DEXTROMETHORPHANUM
DEXTROMETORFANO
Dextrometorfano [INN-Spanish]
Dextrometorphan
Dextromorphan
Dexyromethorphan
Diabe-Tuss DM Syrup
Dimacol
DIMETANE-DX
Dimetapp DM
DM
D-Methorphan
D-Methorphan hydrobromide
Dormetan
Dormethan
Drixoral cough
Drixoral cough & congestion
Drixoral cough & sore throat
DXM
|
Endotussin-NN
Endotussin-NN pediatric
Hihustan M.
Hold
Hold DM
Hydrobromide, dextromethorphan
Hydrochloride, dextromethorphan
Koffex DM
L-3-Methoxy-17-methylmorphinan
Levomethorphan
Levomethorphan [Ban:Dcf:Inn]
Levomethorphane
Levomethorphane [INN-French]
Levomethorphanum
Levomethorphanum [INN-Latin]
Levometorfano
Levometorfano [INN-Spanish]
L-Methorphan
Medicon
Methorate
Methorate Hydrobromide
Methorphan
Metrorat
Naldecon-DX
Novahistex DM
Novahistine DM
Ornex severe cold formula
Orthoxicol
PediaCare 1
PediaCare cough-cold formula
Pertussin CS Children's Strength
Pertussin DM Extra Strength
Prestwick_686
Racemethorphan
Robitussin CF
Robitussin cold & cough
Robitussin cough calmers
Robitussin DM
Robitussin maximum strength cough
Robitussin Maximum Strength Cough Suppressant
Robitussin Pediatric
Robitussin pediatric cough
Robitussin pediatric cough & cold
Robitussin Pediatric Cough Suppressant
Robitussin pediatric night relief
Romilar
Rondec DM
Ru-tuss expectorant
St. joseph cough syrup
Sucrets 4 Hour Cough Suppressant
Sudafed cough syrup
Triaminic
Triaminic DM Long Lasting for Children
Trind-DM
Trocal
Tusilan
Tussade
Tussar DM
Tussi-organidin
Tussi-organidin DM NR
Tussi-organidin DM-S NR
Tylenol cold and flu multi-symptom
Tylenol cold and flu no drowsiness
Tylenol cold no drowsiness
Tylenol cough + decongestant liquid
Tylenol cough liquid
Tylenol flu no drowsiness gelcaps
Vicks 44 Cough Relief
Viro-med
Δ-methorphan
|
|
23 |
|
Desipramine |
Approved, Investigational |
Phase 2 |
|
50-47-5 |
2995 |
Synonyms:
3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine
5-(gamma-Methylaminopropyl)iminodibenzyl
5-(g-Methylaminopropyl)iminodibenzyl
5-(Γ-methylaminopropyl)iminodibenzyl
Apo desipramine
Apo-desipramine
Apotex brand OF desipramine hydrochloride
Aventis behring brand OF desipramine hydrochloride
Aventis brand OF desipramine hydrochloride
Demethylimipramine
DÉMÉTHYLIMIPRAMINE
Desimipramine
Desimpramine
Desipramin
Desipramina
DESIPRAMINE
Désipramine
Desipramine Hcl
Desipramine hydrochloride
Desipraminum
Desmethylimipramine
Dezipramine
Dimethylimipramine
DMI
EX-4355
EX-4355|JB-8181|Norpramin®|Pertrofane®|Treyzafagit®
Hydrochloride, desipramine
JB-8181
Methylaminopropyliminodibenzyl
Monodemethylimipramine
|
N-(3-Methylaminopropyl)iminobibenzyl
Norimipramine
Norpramin
Norpramine
Novartis brand OF desipramine hydrochloride
Novo desipramine
Novo-desipramine
Novopharm brand OF desipramine hydrochloride
Nu desipramine
Nu pharm brand OF desipramine hydrochloride
Nu-desipramine
Nu-pharm brand OF desipramine hydrochloride
Pentofran
Pertofran
Pertofrane
PERTROFANE
Pertrofran
Petylyl
Pharmascience brand OF desipramine hydrochloride
PMS Desipramine
PMS-Desipramine
Ratio desipramine
Ratio-desipramine
Ratiopharm brand OF desipramine hydrochloride
Rhône poulenc rorer brand OF desipramine hydrochloride
Rhône-poulenc rorer brand OF desipramine hydrochloride
Sertofran
Temmler brand OF desipramine hydrochloride
TREYZAFAGIT
|
|
24 |
|
Mecasermin |
Approved, Investigational |
Phase 2 |
|
68562-41-4 |
|
Synonyms:
CEP-151
Human somatomedin C
IGF1
IGF-1
INCRELEX
INSULIN-LIKE GROWTH FACTOR 1
INSULIN-LIKE GROWTH FACTOR I
|
MECASERMIN
MECASERMIN RECOMBINANT
MECASERMIN RINFABATE
Mecasermina
MECHANO GROWTH FACTOR
MYOTROPHIN
SOMATOMEDIN-C
|
|
25 |
|
Antioxidants |
|
Phase 2 |
|
|
|
26 |
|
Antirheumatic Agents |
|
Phase 2 |
|
|
|
27 |
|
Adjuvants, Immunologic |
|
Phase 2 |
|
|
|
28 |
|
(T,G)-A-L |
|
Phase 2 |
|
|
|
29 |
|
Glatiramer Acetate |
|
Phase 2 |
|
|
|
30 |
|
Immunosuppressive Agents |
|
Phase 1, Phase 2 |
|
|
|
31 |
|
Immunologic Factors |
|
Phase 1, Phase 2 |
|
|
|
32 |
|
L 647318 |
|
Phase 2 |
|
|
|
33 |
|
Dihydromevinolin |
|
Phase 2 |
|
|
|
34 |
|
Antimetabolites |
|
Phase 2 |
|
|
|
35 |
|
Hypolipidemic Agents |
|
Phase 2 |
|
|
|
36 |
|
Anticholesteremic Agents |
|
Phase 2 |
|
|
|
37 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 2 |
|
|
|
38 |
|
Lipid Regulating Agents |
|
Phase 2 |
|
|
|
39 |
|
Fingolimod Hydrochloride |
|
Phase 1, Phase 2 |
|
162359-56-0 |
|
Synonyms:
FINGOLIMOD
FINGOLIMOD HCL
FTY-720
|
FTY720 HYDROCHLORIDE
FTY-720 HYDROCHLORIDE
GILENYA
|
|
40 |
|
Chlorpheniramine, phenylpropanolamine drug combination |
|
Phase 2 |
|
|
|
41 |
|
Excitatory Amino Acid Antagonists |
|
Phase 2 |
|
|
|
42 |
|
Respiratory System Agents |
|
Phase 2 |
|
|
|
43 |
|
Antitussive Agents |
|
Phase 2 |
|
|
|
44 |
|
Hypoglycemic Agents |
|
Phase 2 |
|
|
|
45 |
|
Adrenergic Agents |
|
Phase 2 |
|
|
|
46 |
|
Antidepressive Agents, Tricyclic |
|
Phase 2 |
|
|
|
47 |
|
Antidepressive Agents |
|
Phase 2 |
|
|
|
48 |
|
Anesthetics, Intravenous |
|
Phase 2 |
|
|
|
49 |
|
Anesthetics, General |
|
Phase 2 |
|
|
|
50 |
|
Anesthetics, Dissociative |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 69)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Pathogenesis of Rett Syndrome: Natural History and Treatment |
Unknown status |
NCT00069550 |
Phase 3 |
dextromethorphan;donepezil hydrochloride |
2 |
A 40-Week, Open-label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome |
Completed |
NCT04279314 |
Phase 3 |
Trofinetide |
3 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome |
Completed |
NCT04181723 |
Phase 3 |
Trofinetide |
4 |
A Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in Patients With Rett Syndrome |
Completed |
NCT03941444 |
Phase 3 |
ANAVEX2-73;Placebo |
5 |
Efficacy And Safety Of Risperidone In The Treatment Of Children With Autistic Disorder And Other Pervasive Developmental Disorders: A Canadian, Multicenter, Double-Blind, Placebo-Controlled Study |
Completed |
NCT00261508 |
Phase 3 |
risperidone |
6 |
ANAVEX2-73-RS-003 is a Phase 2/3, Double-blind, Randomized, Placebo-controlled Safety and Efficacy Study in Pediatric Patients With RTT |
Recruiting |
NCT04304482 |
Phase 2, Phase 3 |
ANAVEX2-73 oral liquid;Placebo oral liquid |
7 |
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome |
Active, not recruiting |
NCT04988867 |
Phase 2, Phase 3 |
Trofinetide |
8 |
An Open-Label Extension Study of Continuing Treatment With Trofinetide for Rett Syndrome |
Enrolling by invitation |
NCT04776746 |
Phase 3 |
trofinetide |
9 |
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome |
Terminated |
NCT03848832 |
Phase 3 |
GWP42003-P;Placebo |
10 |
A Randomised, Double-Blind, Placebo-Controlled 6-month Study to Evaluate the Efficacy, Safety, and Tolerability of Sarizotan in Patients With Rett Syndrome With Respiratory Symptoms |
Terminated |
NCT02790034 |
Phase 2, Phase 3 |
Sarizotan low dose;Sarizotan high dose;Placebo |
11 |
An Open-label Extension Trial to Investigate the Long-term Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome |
Terminated |
NCT04252586 |
Phase 3 |
GWP42003-P |
12 |
Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin: An Open-label, 10-subject Clinical Trial of UX007 (Triheptanoin) in the Treatment of Mitochondrial Dysfunction in Participants With Rett Syndrome, Dyskinesia, and Epilepsy |
Unknown status |
NCT02696044 |
Phase 2 |
triheptanoin |
13 |
Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome. |
Unknown status |
NCT03059160 |
Phase 2 |
Tridecanoic Acid |
14 |
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome |
Unknown status |
NCT04041713 |
Phase 2 |
Rett-T |
15 |
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome |
Completed |
NCT02715115 |
Phase 2 |
NNZ-2566;Placebo |
16 |
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation Study of NNZ-2566 in Rett Syndrome |
Completed |
NCT01703533 |
Phase 2 |
NNZ-2566;Placebo |
17 |
A Double-Blind, Randomized, Placebo-Controlled, Dose Titration Study of ANAVEX2-73 in Patients With Rett Syndrome |
Completed |
NCT03758924 |
Phase 2 |
ANAVEX2-73;Placebo |
18 |
Pharmacological Treatment of Rett Syndrome With 3-Hydroxy-3 Methylglutaryl-coenzyme A Reductase Inhibitor-Lovastatin (Mevacor) |
Completed |
NCT02563860 |
Phase 2 |
Lovastatin |
19 |
A Phase 1 Clinical Study to Assess Safety and Efficacy of Oral Fingolimod (FTY720) in Children With Rett Syndrome. |
Completed |
NCT02061137 |
Phase 1, Phase 2 |
fingolimod (FTY720) |
20 |
Pilot Study of the Effects of the Desipramine on the Neurovegetative Parameters of the Child With Rett Syndrome |
Completed |
NCT00990691 |
Phase 2 |
Administration of a high dose of desipramine;Administration of a low dose of desipramine;Administration of a placebo |
21 |
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability and Efficacy of Oral Ketamine for Patients With Rett Syndrome |
Completed |
NCT03633058 |
Phase 2 |
Ketamine |
22 |
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection) |
Completed |
NCT01777542 |
Phase 2 |
Recombinant Human Insulin Growth Factor 1 (rhIGF-1);Placebo |
23 |
Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone) |
Completed |
NCT02153723 |
Phase 2 |
Glatiramer Acetate |
24 |
A Phase 2A Randomized, Placebo Controlled Trial of EPI-743 in Children With Rett Syndrome |
Completed |
NCT01822249 |
Phase 2 |
EPI-743;Placebo |
25 |
Placebo Controlled Trial of Dextromethorphan in Rett Syndrome |
Completed |
NCT01520363 |
Phase 2 |
dextromethorphan;placebo |
26 |
Open-label, Randomized, Dose-escalation and Dose-expansion Study of the Safety and Preliminary Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, in the Treatment of Adult Females With Rett Syndrome |
Recruiting |
NCT05606614 |
Phase 1, Phase 2 |
|
27 |
Phase 2, Double-Blind, Randomized, Placebo-Controlled Clinical Study of VYNT-0126 in the Treatment of Rett Syndrome in Adult Female Patients |
Not yet recruiting |
NCT05625568 |
Phase 2 |
VYNT-0126;Placebo |
28 |
Trial of Dextromethorphan in Rett Syndrome |
Terminated |
NCT00593957 |
Phase 2 |
Dextromethorphan |
29 |
An Open Label, Exploratory Study to Investigate the Treatment Effect og Glatiramer Acetate (Copaxone ®) on Girls Woth Rett Syndrome |
Unknown status |
NCT02023424 |
Phase 1 |
Glatiramer Acetate (Copaxone®) |
30 |
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With IGF-1 |
Completed |
NCT01253317 |
Phase 1 |
rhIGF-1 |
31 |
Ketamine for the Treatment of Rett Syndrome: An Exploratory Trial |
Terminated |
NCT02562820 |
Phase 1 |
|
32 |
Implementing Telehealth Support to Increase Physical Activity in Girls and Women With Rett Syndrome |
Unknown status |
NCT04167059 |
|
|
33 |
Study of Biological Parameters in 100 Girls With RETT Syndrome |
Unknown status |
NCT04014985 |
|
|
34 |
The Findings of Resting-state Functional Magnetic Resonance Imaging , Susceptibility Weighted Imaging and Diffusion Spectrum Imaging in Rett Syndrome |
Unknown status |
NCT02903056 |
|
|
35 |
The Role of Probiotics PS128 in Movement Disorders |
Unknown status |
NCT03259971 |
|
|
36 |
Dysautonomic Signs Among MECP2boys |
Unknown status |
NCT04502199 |
|
|
37 |
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome |
Completed |
NCT00299312 |
|
|
38 |
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi |
Completed |
NCT02670694 |
|
|
39 |
A Systematic Metabolic Approach to the Evaluation of Nutrition in Rett Syndrome According to the Cardiorespiratory Phenotype in Dutch Rett Girls |
Completed |
NCT00786071 |
|
|
40 |
Rett Syndrome, MECP2 Duplication, and Rett-Related Disorders Consortium, Rare Disease Clinical Research Network: Neurophysiologic Correlates |
Completed |
NCT03077308 |
|
|
41 |
Parent-child Interaction and Communication in Families Who Have a Child With Rett Syndrome or Angelman Syndrome |
Completed |
NCT03720028 |
|
|
42 |
Osteoporosis in RETT Syndrome. Understanding the Mechanisms and Identification of Biomarkers. |
Completed |
NCT02110797 |
|
|
43 |
Functional Abilities in Rett Syndrome |
Completed |
NCT00630422 |
|
|
44 |
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol |
Completed |
NCT02738281 |
|
|
45 |
Feasibility and Effectiveness of an Individualized 12-week 'Uptime' Participation Intervention (U-PART) in Girls and Women With Rett Syndrome |
Completed |
NCT03848442 |
|
|
46 |
Biobanking of Rett Syndrome and Related Disorders Protocol |
Completed |
NCT02705677 |
|
|
47 |
Effects of Creatine Supplementation in Rett Syndrome: A Randomized, Placebo-controlled Trial |
Completed |
NCT01147575 |
|
|
48 |
The Role of Family Functioning in Adaptation to Being a Caregiver of an Individual With Rett Syndrome |
Completed |
NCT00891956 |
|
|
49 |
Study of the Pathogenesis of Rett Syndrome |
Completed |
NCT00004807 |
|
dextromethorphan;topiramate;Donepezil |
50 |
Nutritional Aspects of Rett Syndrome |
Completed |
NCT00004656 |
|
|
Cochrane evidence based reviews: rett syndrome
|